Business Context and Reporting Period
Company: Integer Holdings Corp (ITGR)
Filing Type: Form 10-Q (Unaudited)
Reporting Period: Quarter and six months ended July 3, 2026
Business Overview: Integer is a medical device contract development and manufacturing organization (CDMO) serving cardio/vascular, neuromodulation, and cardiac rhythm management markets. The company operates as a single segment.
Key Financial Metrics
| Metric (in thousands) | Q2 2026 | Q2 2025 | 6M 2026 | 6M 2025 |
|---|---|---|---|---|
| Sales | $464,110 | $476,494 | $903,690 | $913,886 |
| Gross Profit | $112,942 | $129,152 | $222,537 | $249,470 |
| Gross Margin | 24.3% | 27.1% | 24.6% | 27.3% |
| Operating Income | $34,528 | $59,338 | $66,397 | $108,890 |
| Operating Margin | 7.4% | 12.5% | 7.3% | 11.9% |
| Net Income | $23,605 | $37,009 | $40,111 | $14,522 |
| Diluted EPS | $0.69 | $1.04 | $1.17 | $0.41 |
| Cash from Operations (6M) | $84,430 (2026) vs $75,138 (2025) | |||
| Long-Term Debt | $1,237,883 (July 3, 2026) | |||
| Cash & Equivalents | $21,375 (July 3, 2026) |
Material Changes vs. Prior Period
- Revenue Decline: Sales decreased 2.6% in Q2 and 1.1% in the first six months of 2026 compared to 2025. This was driven by lower sales in Cardio & Vascular and Other Markets, attributed to lower-than-anticipated market adoption of three new products and the exit of a portable medical product line.
- Margin Compression: Gross margin declined to 24.3% in Q2 2026 from 27.1% in Q2 2025, primarily due to lower fixed cost absorption resulting from reduced production volumes.
- Expense Increases: Operating expenses rose 12.3% in Q2 2026. Selling, General, and Administrative (SG&A) expenses increased 9.0%, driven by professional fees related to a stockholder activist matter and defense of a securities class action lawsuit. Restructuring and other charges surged 256% to $9.4 million, including a $5.9 million fixed asset impairment charge.
- Income Tax Benefit: The company recorded an income tax benefit of $0.3 million in Q2 2026 (effective rate -1.3%) compared to a provision of $8.6 million in Q2 2025. The 2025 rate was skewed by a non-recurring $46.7 million debt conversion inducement expense.
Guidance, Outlook, and Material Events
- Merger Agreement (Subsequent Event): On August 2, 2026, Integer entered into a definitive agreement to be acquired by Armstrong Parent, Inc. (an affiliate of Kohlberg Kravis Roberts & Co. L.P.). The transaction provides for a cash consideration of $127.00 per share. Upon consummation, the company will be delisted from the NYSE and become privately held.
- Termination Fees: The Merger Agreement includes a $154 million termination fee payable by Integer under certain conditions (e.g., accepting a superior proposal) and a $307 million fee payable by the acquirer if they fail to close due to breach.
- Outlook: Management expects 2026 year-over-year sales growth to be impacted by the lower adoption of new products, describing the magnitude of these changes as "highly unusual."
- Liquidity: The company maintains $744.7 million in available borrowing capacity under its Revolving Credit Facility. Management believes cash flows and borrowing capacity are sufficient for the next 12 months.
- Legal Proceedings: A securities class action lawsuit filed in December 2025 was dismissed by the court in June 2026, though the plaintiff filed a notice of appeal in July 2026.
Investor Verification Checklist
- Merger Consummation: Verify the status of shareholder approval and regulatory clearances required to close the $127/share acquisition.
- Product Adoption: Assess the long-term viability of the three new products cited as drivers for revenue decline and whether the "highly unusual" adoption issues are temporary or structural.
- Restructuring Costs: Confirm the cash impact of the $5.9 million asset impairment and the remaining restructuring reserve of $1.5 million.
- Debt Covenants: Review compliance with the Total Net Leverage Ratio (currently ~2.9:1.0) and interest coverage ratio (currently ~14.0:1.0) under the Senior Secured Credit Facilities.
- Legal Exposure: Monitor the appeal of the dismissed securities class action lawsuit and potential costs associated with the stockholder activist matter.